These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1555749)

  • 21. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines.
    Hirata M; Itoh M; Tsuchida A; Ooishi H; Hanada K; Kajiyama G
    FEBS Lett; 1996 Apr; 383(3):241-4. PubMed ID: 8925905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
    Takács T; Nagy I; Pap A; Varró V
    Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues.
    Niederau C; Niederau M; Williams JA; Grendell JH
    Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo comparison of inhibition with proglumide and CR-1409 of cholecystokinin-induced pressure in the biliary tract of the guinea pig.
    Poston GJ; MacLellan DG; Hashimoto T; Upp JR; Townsend CM; Thompson JC
    Surg Gynecol Obstet; 1990 Mar; 170(3):217-22. PubMed ID: 2305348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.
    Staley J; Jensen RT; Moody TW
    Peptides; 1990; 11(5):1033-6. PubMed ID: 2178246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
    Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
    Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans.
    Adler G; Beglinger C; Braun U; Reinshagen M; Koop I; Schafmayer A; Rovati L; Arnold R
    Gastroenterology; 1991 Feb; 100(2):537-43. PubMed ID: 1702077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines.
    Ohlsson B; Fredäng N; Axelson J
    Scand J Gastroenterol; 1999 Dec; 34(12):1224-9. PubMed ID: 10636070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of combined use of CR 1505 with UFT on tumor growth of transplanted pancreatic cancer in the Syrian golden hamster: preliminary report].
    Tomioka M; Miyazaki N; Yamamoto M; Saito Y
    Nihon Geka Gakkai Zasshi; 1992 Jan; 93(1):106. PubMed ID: 1549090
    [No Abstract]   [Full Text] [Related]  

  • 32. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential mode of action of high- and low-affinity CCK/gastrin receptor antagonists in growth inhibition of gastrin--responsive human gastric adenocarcinoma cells in vitro.
    Piontek MK; Hengels KJ
    Anticancer Res; 1993; 13(3):715-20. PubMed ID: 8317902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide.
    Watson SA; Morris DL; Durrant LG; Robertson JF; Hardcastle JD
    Eur J Cancer; 1992; 28A(8-9):1462-7. PubMed ID: 1355350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of CCK antagonists CR 1409 and CR 1505 on rat pancreatic exocrine secretion in vivo.
    Shiratori K; Shimizu K; Watanabe S; Takeuchi T; Moriyoshi Y
    Pancreas; 1989; 4(6):744-50. PubMed ID: 2813333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats.
    Meereis-Schwanke K; Klonowski-Stumpe H; Herberg L; Niederau C
    Peptides; 1998; 19(2):291-9. PubMed ID: 9493861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of cholecystokinin and its antagonists on the GI tract. Potent inhibition of gastrointestinal motility by loxiglumide].
    Schmidt WE
    Fortschr Med; 1992 Oct; 110(28):521-2. PubMed ID: 1398411
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibitory effect of a cholecystokinin antagonist on the proliferative response of the pancreas to pancreatobiliary diversion.
    Watanapa P; Efa EF; Beardshall K; Calam J; Sarraf CE; Alison MR; Williamson RC
    Gut; 1991 Sep; 32(9):1049-54. PubMed ID: 1916490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.
    Watanapa P; Flaks B; Oztas H; Deprez PH; Calam J; Williamson RC
    Br J Cancer; 1993 Apr; 67(4):663-7. PubMed ID: 8471422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
    Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
    J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.